On Monday, Sana Biotechnology Inc (NASDAQ: SANA) was -4.97% drop from the session before settling in for the closing price of $3.22. A 52-week range for SANA has been $1.52 – $12.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 17.68%. With a float of $122.69 million, this company’s outstanding shares have now reached $223.11 million.
Let’s determine the extent of company efficiency that accounts for 328 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Sana Biotechnology Inc (SANA) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Sana Biotechnology Inc stocks. The insider ownership of Sana Biotechnology Inc is 45.05%, while institutional ownership is 52.42%. The most recent insider transaction that took place on Jan 16 ’25, was worth 289,500. Before that another transaction happened on Jan 08 ’25, when Company’s See Remark 1 sold 290,912 for $6.49, making the entire transaction worth $1,887,320. This insider now owns 4,541,511 shares in total.
Sana Biotechnology Inc (SANA) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 17.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 17.56% during the next five years compared to -83.13% drop over the previous five years of trading.
Sana Biotechnology Inc (NASDAQ: SANA) Trading Performance Indicators
You can see what Sana Biotechnology Inc (SANA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.41, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.87 in one year’s time.
Technical Analysis of Sana Biotechnology Inc (SANA)
Looking closely at Sana Biotechnology Inc (NASDAQ: SANA), its last 5-days average volume was 4.11 million, which is a drop from its year-to-date volume of 16.03 million. As of the previous 9 days, the stock’s Stochastic %D was 47.01%. Additionally, its Average True Range was 0.52.
During the past 100 days, Sana Biotechnology Inc’s (SANA) raw stochastic average was set at 26.64%, which indicates a significant increase from 20.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 128.63% in the past 14 days, which was lower than the 180.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.56, while its 200-day Moving Average is $4.93. However, in the short run, Sana Biotechnology Inc’s stock first resistance to watch stands at $3.16. Second resistance stands at $3.26. The third major resistance level sits at $3.38. If the price goes on to break the first support level at $2.94, it is likely to go to the next support level at $2.81. Should the price break the second support level, the third support level stands at $2.71.
Sana Biotechnology Inc (NASDAQ: SANA) Key Stats
There are 223,269K outstanding shares of the company, which has a market capitalization of 683.20 million. As of now, sales total 0 K while income totals -283,260 K. Its latest quarter income was 0 K while its last quarter net income were -59,920 K.
